[Comparative characteristics and analysis of the anti-curare action of cholinopotentiating agents].
D000549:Ambenonium Chloride / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D001001:Anura; D001921:Brain / Q000201:enzymology; D002802:Cholinesterases / Q000378:metabolism; D005260:Female; D005702:Galantamine / Q000494:pharmacology / Q000633:toxicity; D051379:Mice; D008916:Miotics / Q000494:pharmacology / Q000633:toxicity; D009388:Neostigmine / Q000494:pharmacology / Q000633:toxicity; D063065:Organophosphonates / Q000494:pharmacology / Q000633:toxicity; D010277:Parasympathomimetics / Q000494:pharmacology*; D010710:Phosphates / Q000494:pharmacology / Q000633:toxicity; D010830:Physostigmine / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D014403:Tubocurarine / Q000037:antagonists & inhibitors*
D008916:Miotics; D063065:Organophosphonates; D010277:Parasympathomimetics; D010710:Phosphates; D005702:Galantamine; D009388:Neostigmine; D000549:Ambenonium Chloride; D010830:Physostigmine; D002802:Cholinesterases; D014403:Tubocurarine
Sravnitel'naia kharakteristika i analiz antikurarnogo deĭstviia kholinopotentsiruiushchikh sredstv.